Instructions to the Authors

SUBMISSION OF MANUSCRIPT & REVIEW PROCEDURE

  • The material submitted for publication should be exclusively to the journal "Medical Forum Monthly Lahore" manuscript sent or accepted elsewhere for publication should not be submitted.
  • Manuscript submitted in our online Editorial System at medicalforummonthly.com in the MS Word in one file starting from title to references included tables or figures.
  • Submission of the manuscript also by two hard copies of laser print.
  • Submission of manuscript also by Email on med_forum@hotmail.com or medicalforum@gmail.com.
  • Letter of undertaking from all authors. (Click here to get letter of undertaking)
  • Letter of contribution of all authors.
  • Letter from Institutional Review Board (IRB)/ Ethical Review Board (ERB) is also required. This letter needs date & reference number before the start of study.
  • Multiple or duplicate submission of the same work to other journal should be avoided.
  • Title page; complete title of manuscript, name of all authors with their highest qualification, department, institution, cell number, e-mail address, postal address etc. should mentioned.
  • Short running title of article, number of figures, tables and total workout from title to last page.

INITIAL ASSESSMENT 

  • Every submitted article will be evaluated by editorial team.

PEER REVIEW  

  • After initial assessment, two external reviewers of subject specialists identified by the editor, will be assessed. Two-week time will be given for the review of manuscript to the reviewers.

PLAGIARISM

  • Manuscripts are screened for plagiarism using "Turnitin" software.

AUTHORSHIP CRITERIA

  • The ICMJE recommends that authorship be based on the following 4 criteria:
  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work.
  • Drafting the work or revising it critically for important intellectual content
  • Final approval of the version to be published
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

NON AUTHORSHIP CRITERIA 

  • Contributors who meet fewer than all 4 of the above criteria for authorship should not be listed as authors, but they should be acknowledged. Examples of activities that alone (without other contributions) do not qualify a contributor for authorship are acquisition of funding; general supervision of a research group or general administrative support; and writing assistance, technical editing, language editing, and proofreading.
  • Those whose contributions do not justify authorship may be acknowledged individually or together as a group under a single heading (e.g., "Clinical Investigators" or "Participating Investigators") and their contributions should be specified (e.g., "served as scientific advisors," "critically reviewed the study proposal," "collected data," "provided and cared for study patients, "participated in writing or technical editing of the manuscript").

AUTHORS RESPONSIBILITIES

Reporting standards

  • Authors of original research reports should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Data access and retention

  • Authors could be asked to provide the raw data of their study together with the paper for editorial review and should be prepared to make the data publicly available if practicable. In any event, authors should ensure accessibility of such data to other competent professionals for at least ten years after publication (preferably via an institutional or subject-based data repository or other data center), provided that the confidentiality of the participants can be protected and legal rights concerning proprietary data do not preclude their release.

Originality, plagiarism and acknowledgement of sources

  • Authors will submit only entirely original works, and will appropriately cite or quote the work and/or words of others. Publications that have been influential in determining the nature of the reported work should also be cited.

Multiple, redundant or concurrent publication

In general, papers describing essentially the same research should not be published in more than one journal. Submitting the same paper to more than one journal constitutes unethical publishing behavior and is unacceptable.

ARTICLE CATEGORIES

ORIGINAL ARTICLE:

  • 2000 to 3000 Words including title page, tables or figures and references.
  • Not more than 4 Tables or Figures.
  • 200 to 250 words of Structured Abstract.
  • 3-10 Keywords.
  • 20-25 (local and international) References.
  • 50% references from last 3 years at the time of submission.
  • 60% reference from the journals.
  • Reference from International Journals taken upto 5 years and from National Journals upto 10 years can be cited

REVIEW ARTICLE:

  • 3000 Words with at least not more than 40 references.
  • Not more than 3 Tables or Figures.
  • 200 to 250 words of Structured Abstract.
  • 3 Keywords.
  • 40 (local and international) References.
  • 50% references from last 3 years at the time of submission.
  • 60% reference from the journals.

SHORT COMMUNICATIONS OR CASE REPORTS:

  • 1000-1200 Words
  • 150 words Non Structured Abstract.
  • 2 Tables or illustrations
  • 6 References.

EVIDENCE BASED REPORTS:

  • 1000-1200 Words
  • 150 words Non Structured Abstract.
  • 2 Tables or illustrations
  • 10-12 References.

CLINICAL CASE REPORTS:  

  • 800 Words
  • 100-150 words Non Structured Abstract.
  • 1-2 Tables or illustrations           
  • 10-12 References.

LETTER TO EDITOR:  

  • 350 words
  • 5-6 References

GUEST EDITORIAL:  

  • 1000 Words
  • 5-8 References.

TEXT ARRANGEMENTS  

TITLE OF THE ARTICLE:  

  • Complete title of manuscript, name of all authors with their highest qualification, department, institution, cell number, e-mail address, postal address etc.

ABSTRACT

  • Abstract should not more than 250 words.
  • In Original Article, it should consist of the following seven subheadings:
  • Objective
  • Study Design
  • Place and Duration of study
  • Methods
  • Results
  • Conclusion
  • Keywords 3 to 10

INTRODUCTION

  • The start of the introduction should be Relevant. Reasons and Importance of the study should be clear.
  • Give only strictly pertinent References and do not include data or conclusions from the work being reported.

METHODS

  • If the method is already existing give reference but if new give its detail information.
  • If use of any drug, give its generic name.
  • For patient, give age and sex.
  • Statistical method must be mentioned
  • The Population taken for the study should be uniform and Sample selection criteria should be reliable. Inclusion & Exclusion criteria should be clearly specified.

RESULTS

  • Present your results in a logical sequence must be in the form of Text, Tables, illustrations, Figures and Graphs.
  • The contents of the tables should not repeat, only a reference to the table number may be given.

DISCUSSION  

  • Present finding, variations and similarities with other studies in the field. New and important aspects of your study and conclusions you should mentioned here that the hypothesis of your study is true, false or no conclusion can be derived.

CONCLUSION  

  • In this link write the goals of the study.

CONFLICT OF INTEREST  

  • Any conflict for interest should be declared by all authors.

DISCLOSURE  

  • Nonmonetary disclosures regarding being part of thesis or dissertation, a pilot projector an ongoing study should be made explicitly at the time of submission.

FUNDING  

  • Any company or institution who has financially contributed to the study must be acknowledged.

RECOMMENDATIONS

  • When appropriate, may be included.

ACKNOWLEDGMENTS

  • List of all contributors who do not meet the criteria for Authorship, such as a person who provided purely technical help, writing assistance or department chair who provided only general support.
  • Financial & Material support should be acknowledged.

REFERENCES  

  • References from International Journals taken upto 5 years and National Journals upto 10 years can be cited.
  • It should be in the Vancouver Style. References should be numbered in the order in which they are cited in the text.
  • At the end of the article, the full list of references should give the names and initials of all the authors. (If authors are more than 6, then et al should be followed after the 6th name).

Article in Journals

  1. Standard Journal Article

Up to six authors: Alam JM, Baig JA, Mahmood SR, Sultana I, Shaheen R, Waheed A. Evaluation of urinary pro-tein to creatinine ratio as a predictor of end-stage renal disease. KUST MedJ 2009; 1(1): 2-5.

More than six authors: List the first six authors followed by et al. Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E, et al. Childhood leu-kaemia in Europe after Chernobyl: 5year follow-up. Br J Cancer 1996; 73:1006-12.

  1. Organization as author

The Cardiac Society of Australia and New   Zealand.   Clinical   exercise   stress testing. Safety and performance guidelines.  Med J Aust 1996; 164:  282-4.

  1. No Author given

Cancer in South Africa [editorial]. S Afr Med J 1994; 84:15.

  1. Article not in English:

(Note:  NLM  translates  the  title  to  English,  encloses  the  translation  in  square brackets, and adds an abbreviated language designator.) Ryder TE, Haukeland EA, Solhaug JH. Bilateral infrapatellar seneruptur hostidligere frisk kvinne. Tidsskr Nor Laegeforen 1996; 116: 41-2.

  1. Volume with supplement:

Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-82.

  1. Issue with supplement

Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2):89-97.

  1. Volume with part

Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-in-sulin  dependent diabetes  mellitus. Ann Clin Biochem 1995; 32(Pt 3): 303-6.

  1. Issue with part:

Poole GH, Mills SM.  One hundred consecutive cases of flap lacerations of the leg in ageing patients. N Z MedJ 1994; 107 (986 Pt 1): 377-8.

  1. Issue with no volume:

Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-4.

  1. No issue or volume:

Browell DA, Lennard TW. Immuno-logic status of the cancer patient and the effects of blood transfusion on antitumor responses. Curr Opin GenSurg 1993: 325-33.

  1. Pagination in roman numerals:

Fisher GA, Sikic BI. Drug resistance in clinical oncology and hematology. Introduction.  Hematol Oncol Clin North Am 1995 Apr;9(2):xi-xii.

  1. Type of Article indicated as needed:

Enzensberger W, Fischer PA. Metro-nome in Parkinson’s disease [letter]. Lancet 1996;347:1337. Clement J, De Bock R. Hematological complications of hantavirus nephropathy (HVN) [abstract]. Kidney Int 1992; 42: 1285.

  1. Article containing retraction:

Garey CE, Schwarzman AL, Rise ML, Seyfried TN.  Ceruloplasmin gene defect associated with epilepsyin EL mice [retraction of Garey CE, Schwarzman AL, Rise ML, Seyfried TN. In: Nat Genet 1994; 6: 426-31]. Nat Genet 1995; 11: 104.

  1. Article retracted:

Liou GI, Wang M, Matragoon S. Pre-cocious IRBP gene expression during mouse development [retracted in Invest Ophthalmol Vis Sci 1994; 35: 3127].  Invest Ophthalmol Vis Sci 1994; 35: 1083-8.

  1. Article with published erratum:

Hamlin JA, Kahn AM. Herniography insymptomatic patients following ingui-nal hernia repair [published erratum appears in West J Med 1995;162:278].West J Med 1995;162:28-31.

 Book and Other Monographs:

(Note:   Previous   Vancouver   style   incorrectly had a comma rather thana semicolon between the publisher and the date.)

  1. Personal Author(s):

Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers;1996.

  1. Editor(s), Compiler(s) as Author:

Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

  1. Organization as author and publisher:

Institute of Medicine (US). Looking at the future of the Medicaid program. Washington: The Institute; 1992.

  1. Chapter in a book:

(Note:   Previous   Vancouver   style   had a colon rather than a p before pagination.) Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hyperten-sion: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78.

  1. Conference proceedings:

Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neuro-physiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.

  1. Conference paper:

Bengtsson S, Solheim BG. Enforce-ment of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. Amsterdam:  North-Holland; 1992. p. 1561-5.

  1. Scientific or Technical Report

Issued by funding/sponsoring agency: Smith P, Golladay K. Payment for du-rable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX): Dept. of Health and Human Services (US), Office of Evaluation and Inspections; 1994 Oct. Report No.:  HHSIGOEI69200860.  Issued by performing agency: Field MJ, Tranquada RE, Feasley JC, editors. Health services research: work force and educational issues. Washington: National   Academy   Press; 1995.  Contract No.:  AHCPR282942008.  Sponsored by the Agency for Health Care Policy and Research.

  1. Dissertation:

Kaplan SJ. Post-hospital home healthcare: the elderly’s access and utilization [dissertation].  St.  Louis (MO): Washington Univ.; 1995.

  1. Patent:

Larsen CE, Trip R, Johnson CR, inventors; Novoste Corporation, assignee. Methods for procedures related to the electrophysiology of the heart. US patent 5,529,067. 1995 Jun 25.

Unpublished Material:

  1. In press

(Note: NLM prefers “forthcoming” because not all items will be printed.) Leshner AI. Molecular mechanisms of cocaine addiction. N Engl J Med. In press 1996.

Electronic Material:

  1. Journal Article in Electronic Format

Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5];1(1):[24 screens]. Available from: URL:

  1. Monograph in electronic format

CDI, clinical dermatology illustrated [monograph on CD-ROM]. Reeves JRT, Maibach H. CMEA Multimedia Group, producers. 2nd ed. Version 2.0. San Diego: CMEA; 1995.

  1. Computer File

Hemodynamics   III:   the   ups   and   downs of hemodynamics [computer program]. Version 2.2. Orlando (FL): Computerized Educational Systems;1993.


PROCESSING CHARGES

  • 5000/-
  • Fast Track Processing: 15000/-for local US$ 200/- (for Overseas)

PUBLICATION CHARGES  

  • Original Article 35000/- (for local) up to 4 pages. US$ 400/- (for Overseas)
  • Review Article 35000/- (for local) up to 4 pages. US$ 500/- (for Overseas)
  • Case Report/Brief Communication 20000/- (for local) US$ 300/- (for Overseas)
  • Letters to Editor: 5000/-
  • Note: 5000/- (for local) for each additional page. US$ 50/- (for overseas)
  • Printed Copy: One printed copy will be supplied to the corresponding author. Authors can be order additional copy Rs. 3000/- which include of courier charges.

PAYMENT MODE

  • Processing and publication charges can be given:
  • By Cash OR Through online OR May be through bank draft OR Pay Order
  • Title of Account: Medical Forum Monthly
  • Account No. 0001370043679003
  • IBAN No. PK65HABB0001370043679003
  • Swift Code: HABBKKA-007
  • Name of Bank: Habib Bank Limited
  • Branch Address: Ameen Chamber, Davis Road, Lahore-Pakistan

DEADLINES OF ALL PROCESSES  

  • Submission of Article 12 of every month
  • Initial Assessment of Article 16 of every month
  • Review of Article upto 30/31 of every month
  • Acceptance of Article One to Two month
  • Publication of Article One to Three months
  • Online Publication of Journal 12 of Every Next Month
  • Receipt of Article till publication One to Three months

CONTACT:  

  • Dr. Azhar Masud Bhatti (Editor in Chief)
  • Dr. Nasreen Azhar (Managing Editor)
  • Mohsin Masud Jan (Editor)
  • Address: 75-P, Phase-8, Defence Housing Authority, Lahore.
  • 0300-4879016, 0331-6361436, 0345-4221303, 0345-4221323
  • E-mail: med_forum@hotmail.com OR medicalforum@gmail.com

Website: www.medicalforummonthly.com